Population
transgenic mouse models of heart failure
Design
Editorial
Authors
Loading...
May inform CaMKII-targeted HF therapies; leaves open clinical translation from preclinical models.
This editorial highlights the potential of CaMKII inhibition as a therapeutic strategy to reverse maladaptive cardiac remodeling in heart failure.
Cuello et al. (2016) studied this question.